Skip to main content

Let's Talk About Prognosis

GeriPal's very own Alex Smith recently gave an absolutely fabulous "Ted-like" talk in which he made the statement that "prognosis needs to be a part of everyday medical care."  Unfortunately, as he so eloquently states in the video (which can be watched here), it isn't always taken into account.



To dive a little deeper into the lack of prognosis in health care decision making, lets just take a look at cancer screening.   Individuals with a limited life expectancy are exposed to all the immediate harms from a screening test, yet may not live long enough to see any of the benefit (the concept of lag-time-to-benefit).   Yet, people with limited life expectancy still get these screening tests as evident by the following studies:
This is part of the reason that we created the ePrognosis: Cancer Screening decision support app to help guide conversations with elderly patients of whether to start, stop, or continue breast cancer and/or colorectal cancer screening. We recently updated it to give it a new look and feel, and for all you non-iPhone users, we are close to releasing a version that can be used on any mobile device (and yes, it will remain free of charge).

In Alex's video, he leave the audience with a challenge, one that I'll give to the GeriPal viewers as well.  Alex asks the audience to use "ePrognosis once a week for the next month.   See how it changes your perspective.   See how it changes the conversations you have with your patients."

by: Eric Widera (@ewidera)

The ePrognosis Cancer Screening app

Comments

Yvonne Fried, MD said…
Thank you very much for posting this talk. It speaks to the heart of what I need to do in my medical practice as a gynecologist with an aging patient population. It's always easier to stay in the rut of one's practice behaviors than it is to change. I look forward to working with ePrognosis on my iPhone. Thank you Eric Widera and Steve Jobs.
Laura Newman said…
This is important work, but there remains an immense gap in discussion of palliative care in individuals without cancer diagnoses...perhaps in no small part because their prognostic trajectory is less clear.

Popular posts from this blog

Dying without Dialysis

There is a terrific article in this weeks Journal of Pain and Symptom Management by Fliss Murtagh of King's College in London about the epidemiology of symptoms for patients with advanced renal failure who die without dialysis.  This study is important because while we know that patients with advanced renal failure have a limited life expectancy and the average age of initiation of hemodialysis is increasing, we know little about the alternatives to hemodialysis.  Specifically, we know nothing about symptoms affecting quality of life among patients who elect not to start dialysis (so called "conservative management" - is this the best label?).  This article provides a terrific counterpoint to the article in last years NEJM showing that nursing home residents who initiated hemodialysis tended to die and decline in function (see GeriPal write up here). 

The study authors followed patients with the most advanced form of chronic kidney disease (the new name for renal failu…

Language Matters: Podcast with Brian Block and Anna DeForest

One of our first GeriPal posts was titled "Rant on Terminology," by Patrice Villars, NP.  In the spirit of looking back over our first 10 years, here is the opening paragraph to that post:

News Headlines read: Sen. Edward Kennedy loses battle with cancer. Really, he lost? I thought he died from a malignant brain tumor, an “aggressive” brain tumor. The median survival is less than a year for people for his particular tumor. Kennedy was diagnosed in May of 2008. He lived over 15 months after diagnosis. What a loser. He must not have fought hard enough. Huh? I thought he spent most of his life battling for social and health care reform in America. In this week's GeriPal podcast we take a deeper dive into this issue of language and medicine.  We are joined by guests Anna DeForest, MD, MFA, a resident in Neurology at Yale, and Brian Block, MD, a pulmonary critical care fellow at UCSF.  

Anna recently published a paper in the NEJM describing her reaction to hearing terms like, &…

The Dangers of Fleet Enemas

The dangers of oral sodium phosphate preparations are fairly well known in the medical community. In 2006 the FDA issued it’s first warning that patients taking oral sodium phosphate preparations are at risk for potential for acute kidney injury. Two years later, over-the-counter preparations of these drugs were voluntarily withdrawn by the manufacturers.  Those agents still available by prescription were given black box warnings mainly due to acute phosphate nephropathy that can result in renal failure, especially in older adults. Despite all this talk of oral preparations, little was mentioned about a sodium phosphate preparation that is still available over-the-counter – the Fleet enema.

Why Oral Sodium Phosphate Preparations Are Dangerous 

Before we go into the risks of Fleet enemas, lets spend just a couple sentences on why oral sodium phosphate preparations carry significant risks. First, oral sodium phosphate preparations can cause significant fluid shifts within the colon …